CapEx at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s capex?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported capex of $4.44M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s capex changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s capex decreased by 1.4% year-over-year, from $4.5M to $4.44M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s capex?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s capex has grown at a -3.0% compound annual growth rate (CAGR), from $14.85M to $13.15M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.